Higt dose chemotheray compared with standard chemotherapy and lung radiation in Ewing sarcoma with pulmonary metastases. Results of the European Ewing Tumour Working initiative of National Groups, 99 trial and eWING 2008

التفاصيل البيبلوغرافية
العنوان: Higt dose chemotheray compared with standard chemotherapy and lung radiation in Ewing sarcoma with pulmonary metastases. Results of the European Ewing Tumour Working initiative of National Groups, 99 trial and eWING 2008
المؤلفون: DIRKSEN U, BRENNAN B, LE DELEY MC, COZIK N, VAN DEN BERG H, BHADRI V, BRICHARD B
المساهمون: UCL - SSS/IREC - Institut de recherche expérimentale et clinique, UCL - SSS/IREC/PEDI - Pôle de Pédiatrie, UCL - (SLuc) Service d'hématologie et d'oncologie pédiatrique
المصدر: J Clin Oncol, Vol. 25, no.n-a, p. n-a (2019)
سنة النشر: 2019
الوصف: The R2Pulm trial was conducted to evaluate the effect of busulfan-melphalan high-dose chemotherapy with autologous stem-cell rescue (BuMel) without whole-lung irradiation (WLI) on event-free survival (main end point) and overall survival, compared with standard chemotherapy with WLI in Ewing sarcoma (ES) presenting with pulmonary and/or pleural metastases.
اللغة: English
URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______1493::5af92f40804d2999bdbb3d29b0477d5b
https://hdl.handle.net/2078.1/220637
حقوق: OPEN
رقم الأكسشن: edsair.od......1493..5af92f40804d2999bdbb3d29b0477d5b
قاعدة البيانات: OpenAIRE